FDA APPROVES ROSWELL PARK DISCOVERY
Roswell Park Comprehensive Cancer CenterThe U.S. Food and Drug Administration approved the use of Photofrin(r), a light activated drug used in Photodynamic Therapy, for treatment of patients with early-stage lung cancer.